Stunting cell 'antennae' could make cancer drugs work again

June 5, 2018, Institute of Cancer Research
cancer
Killer T cells surround a cancer cell. Credit: NIH

Scientists have uncovered a completely new way to make cancers sensitive to treatment—by targeting antenna-like structures on cells.

Their study found that -resistant have more and longer antennae than those which are killed by treatment.

Blocking the growth of antennae reactivated a range of cancer treatments that had stopped working, the team at The Institute of Cancer Research, London, found.

The researchers identified changes in cellular antennae known as in different types of cancer with resistance to various types of drugs. That suggests that targeting cilia could be a universal way to resensitise cancers to treatment.

The study is published today (Tuesday) in the journal Cell Reports, and was supported by funders including Sarcoma UK, the Wellcome Trust and Cancer Research UK.

Scientists at The Institute of Cancer Research (ICR) - a research institution and charity—studied cells from lung cancer and a soft-tissue cancer called sarcoma in the lab.

The researchers observed that cells that had become resistant to cancer drugs had more, longer cilia—tiny 'antennae' that help cells sense chemical signals.

They then blocked the growth of cilia in drug-resistant cancer cells, and found that their sensitivity to treatment had been restored.Exposure to drugs killed between 35 and 60 per cent of formerly resistant cancer cells—nearly doubling the effectiveness of cancer drugs.

For example, in without cilia, only 39 per cent of cells survived treatment with a drug called erlotinib, compared with 72 per cent of cells that still had cilia.

Blocking important signalling molecules in cilia also restored cells' response to cancer drugs. Lengthening cilia had the opposite effect, causing cells that previously had responded to treatment to develop resistance.

Cancer cells can evolve in many different ways to become resistant to treatment—for example, changing so that they no longer rely on the molecular weaknesses targeted by the drug.

The researchers believe that the role of cilia in drug resistance is largely linked to important cell signalling molecules they contain.

Next, they aim to study molecular networks in cilia, and the effect of changes in the length and stability of the structures, to better understand their role in cancer drug resistance.

Study leader Dr. Barbara Tanos, ICR Fellow in Cancer Therapeutics at The Institute of Cancer Research, London, said:

"We found that small, antenna-like cell structures called cilia play a key role as cancer cells develop resistance to treatment.

"We believe that cilia could help cancer cells become resistant to a wide range of drugs—and therefore that targeting cilia could be a universal way of stripping cancers of their defences.

"Next, we aim to explore changes to cilia in more depth, to build a more detailed picture of how they are linked to cancer drug resistance and how they might be targeted to restore sensitivity to treatment."

Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:

"Combating drug is one of the most important challenges in today. We urgently need a better understanding of the underlying biology that enables cells to evolve and evade .

"This new study has revealed an intriguing link between and cilia—tiny, antenna-like structures that are present on the surface of all cells. The research could open the door to new approaches for attacking cancers, which might block their escape routes from existing treatments."

Explore further: Two drugs are better than one in fight against leukaemia

More information: Cell Reports (2018). DOI: 10.1016/j.celrep.2018.05.016

Related Stories

Two drugs are better than one in fight against leukaemia

March 8, 2018
Adelaide scientists have devised a way to enhance the effectiveness of a patient's leukaemia treatment by using a combination of drugs.

Switching on survival signalling to drive drug resistance

February 27, 2018
Researchers at Queen Mary University of London have discovered that the loss of a single protein- PHLDA1- is sufficient for the development of drug resistance to a type of targeted therapy in endometrial and HER2-positive ...

HIV drug could stop skin cancer becoming drug-resistant

March 14, 2016
An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment, according to a Cancer Research UK-funded study published in Cancer Cell today.

Manipulating the antennae on cells promises new treatments for osteoarthritis

October 27, 2015
Bioengineers from Queen Mary University of London (QMUL) have shown for the first time that lithium chloride, a common drug used to treat mental health disorders, could offer an effective treatment against osteoarthritis ...

Potential therapy identified for aggressive breast cancer

January 25, 2018
The European Cancer Stem Cell Research Institute, based with Cardiff University, has repurposed a current cancer therapy, TRAIL, to find a new treatment for advanced cancers that are resistant to anti-hormone therapy.

Recommended for you

A protein called vaccinia-related kinase 1 may help cancer establish itself in new areas of the body during metastasis

September 25, 2018
Sometimes negative results can point researchers in the right direction.

Method identified to reduce risk of brain damage in leukemia survivors

September 25, 2018
Children with acute lymphoblastic leukemia (ALL) are at an extremely high risk of sepsis compared to the general population. In the first-published study of its kind, St. Jude Children's Research Hospital scientists have ...

Unhealthy lifestyle responsible for 45,000 predicted cases of bowel cancer in next decade

September 25, 2018
A UNSW study shows that a large proportion of bowel cancers in Australia are preventable by adopting a healthy lifestyle – particularly for men.

Fusion hybrids: A newly discovered population of tumor cells

September 24, 2018
In a recent study published in Science Advances, Charles E. Gast and co-workers detail the spontaneous process of cancer cell fusion with white blood cells to produce heterogenous hybrid clones in multiple biological systems, ...

DNA vaccine leads to immune responses in HPV-related head and neck cancer

September 21, 2018
A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. Researchers from the Abramson Cancer Center of the University of ...

In zebrafish, a way to find new cancer therapies, targeting tumor modulators

September 21, 2018
The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes. Looking for a way to test for their presence in zebrafish, their go-to research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.